Eliava Consortium is a joint venture of The Eliava Institute of Bacteriophages, Microbiology and Virology and Eliava Foundation, with the several spin-off companies.

The scientists of the Eliava Institute founded the Eliava Foundation – a non-for-profit organization.

The goal of this consortium is to develop the wide application of Eliava products and services for human, animal, plant and environment protection, to grow and sustain as an organization by using the existing long-term research experience starting since 1923, and to develop it according to the modern quality and standards requirements.

  • Eliava • Institute
  • Eliava • BioPreparations
  • Eliava • Phage Therapy Center
  • Eliava • Diagnostic Center
  • Eliava • Pharmacy

The Eliava Institute was founded in 1923 by distinguished Georgian physician, bacteriologist and phage researcher Prof. George Eliava. An extraordinary role in the institute’s development was played by famous French-Canadian scientist Felix D’Herelle, who first discovered bacteriophages. These scientists developed the joint idea of creating the World Centre of Phage Research and Phage Therapy in Tbilisi, Georgia. Unfortunately, this was the time of Stalin’s Terror. In 1937, Eliava was executed, along with his contemporaries, and D’Herelle never came back to Georgia. During its long history, the Eliava Institute has been known by several respected titles. The best-known was the Scientific-Industrial Union (SIU) “Bacteriophage.” It included two major parts, the Research Institute and Industrial Department, the latter consisting of ten manufacturing units. Altogether, roughly 800 people used to work at the SIU “Bacteriophage”, of whom 120 engaged in research. After the collapse of the Soviet Union, the Industrial Department was partly privatized. During the Soviet period, the Eliava Institute played an important role in the elaboration of novel biological preparations and manufacturing products against almost all major bacterial and viral diseases, such as anthrax, rubies, tuberculosis, brucellosis, salmonellosis, dysentery, etc.

Eliava BioPreparations company is developing and manufacturing therapeutic and prophylactic bacteriophage preparations for the treatment and prophylactic of bacterial infections. Currently, the company is producing six standard bacteriophage products, that are available on the market, together with several costume products, for use in a wide variety of applications. The aim of EBP is to use the unique knowledge and experience of the Eliava Institute to produce highly effective and safe bacteriophage preparations for use in human health, veterinary and environmental care. Eliava Biopreparations company received an exclusive right to use scientific developments and produce preparations developed at the Eliava Institute. Today our product proudly carries a trademark “Developed by George Eliava Institute of Bacteriophages, Microbiology, and Virology”. Eliava BioPreparations Company is the direct successor of the phage production that was operating at the Eliava Institute during the period of almost 70 years. EBP employs more than 30 scientists and phage production specialists, who work or used to work at the Eliava Institute. Phages are part of nature. Without any human involvement, hundreds of billions of phages eliminate the spread of bacteria on our planet every second, keeping the perfect balance. In today’s dynamic world, the problem of bacterial resistance is becoming one of the most challenging threats. Eliava Insitute, together with its group of companies uses bacteriophage microorganisms to target the problem of bacterial resistance against different antibacterial remedies. We have the most advanced knowledge, and longest ongoing history, for the development and use of bacteriophages for science, therapy, veterinary, environmental care, and numerous other applications. Eliava Institute has not stopped innovating for more than 90 years by now, offering modern solutions to bacterial problems.

Eliava Phage Therapy Center is one of the few centers in the world dedicated to phage therapy. It is part of the Eliava Institute of Bacteriophages, Microbiology and Virology, a research facility with broad experience in bacteriophage science and applications since 1923. The Eliava Phage Therapy Center has specialists in the fields of Pediatrics, Internal Medicine, Urology, Gynecology and offers outpatient surgical consultations whose treatment strategies emphasize the use of bacteriophage as the cornerstone of complex medical service.

The Eliava Diagnostic Center was established in 1990 by the leading scientists of "The George Eliava Institute of the Bacteriophages, Microbiology, and Virology". In 2008 diagnostic center with few other companies joined the "Eliava Foundation" - a non-profit organization established by "The George Eliava Institute of the Bacteriophages, Microbiology, and Virology". 2013 Due to the increased demand for bacteriophage drugs, The Eliava Diagnostic Center and the Eliava Foundation have established an Eliava Authorized Pharmacy. In 2020 Branches of Eliava Diagnostic Center and Eliava Authorized began operating in Rustavi. The center currently has 36 employees. 12 employees have a state certificate in laboratory medicine, 9 are Doctors of Science. For the first time in Georgia, this group conducted and still continues highly qualified bacteriological studies, which rely on the deep knowledge of microbiology. Bacteriological examination, in addition to identifying the disease-causing microorganism, determines susceptibility to a variety of medications - including commercial bacteriophages, antibiotics, and antifungal drugs.

Eliava Authorized Pharmacy is an experienced pharmaceutical company that offers a big variety of medications and products for treatment, prophylaxis, and healthy life. The pharmacy has a special license from the Ministry of Labor, Health, and Social Affairs of Georgia for compounding and creating personalized medications. The Pharmacy is preparing high-quality, customized bacteriophage preparations for the treatment of various bacterial infections. The brand name of the pharmacy is connected to the World-known center of Bacteriophage Research and Application – "George Eliava Institute of Bacteriophages, Microbiology and Virology", Tbilisi, Georgia. Eliava Authorized Pharmacy is established in 2013. Co-founders of the pharmacy are “Eliava Analytical-Diagnostic Center- “Diagnozi 90” and a non-for-profit organization “Eliava Foundation – Phage Association of Georgia.“